Navigation Links
Interface Biologics secures $5mm financing and appoints Thomas P. Reeves President and Chief Executive Officer
Date:12/9/2008

TORONTO, Dec. 9 /PRNewswire/ - Interface Biologics Inc. - a privately held developer of novel biomedical-polymers for use in implantable medical devices - is announcing that it has secured a $5mm financing round. Participating in the round were existing investors Covington Capital, VG Partners and BDC Capital. In connection with the financing, Lily Lam from Covington Capital is joining the Board of Directors and Thomas P. Reeves has been appointed the new President and CEO and is also joining the Board of Directors.

"We are fully committed to Interface Biologics and are excited about the continued commercialization opportunities for the Company in the near future. We're pleased to have Tom Reeves joining the Interface team and believe his broad leadership experience - most recently as President and COO of OccuLogix, a medical device company focused on treating age related diseases from the eye (NASDAQ) - will complement our existing scientific and technical expertise as we move into the clinical application and commercialization phase with many of the Company's novel polymer products," said Jeff Courtney, General Partner of VG Partners. "We are also excited to welcome Lily Lam, Vice President Investments, from Covington Capital to the Board of Directors."

"The fact that Interface has been able to raise a significant new round of financing in these difficult economic times is testament to the strength of the organization and its unique products in key applications and rich IP that crosses the spectrum of medical devices," said Tom Reeves, President and CEO of Interface Biologics, Inc. "I am pleased to be joining the Interface team and look forward to leading the team as we capitalize on the research and development work that is solidly established and execute on the commercialization of a number of the products in our portfolio."

About Interface Biologics: Interface Biologics is a biomaterials company based in Toronto, Cana
'/>"/>

SOURCE Interface Biologics Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. DSM Biologics and Crucell Announce Commercial PER.C6(R) Licensing Agreement with Gedeon Richter
2. Savient Submits Biologics License Application (BLA) for pegloticase
3. Therapure Biopharma Inc. announces collaboration with Induce Biologics Inc.
4. Cell Therapeutics Submits Supplemental Biologics License Application for Zevalin Use in First-Line Consolidation Therapy
5. DSM Biologics and MorphoSys AG to Manufacture Fully Human Antibody
6. NuVasive Completes Acquisition of Osteocel Biologics Business
7. Pinnacle Biologics Announces Agreement With pharmexx to Expand Sales Support Activities in Key European Markets
8. Pinnacle Biologics Announces Opening of Executive Offices in Bannockburn, Illinois and the Addition of Sandra Miller to the Board of Directors
9. Pinnacle Biologics Announces Stock Purchase Agreement With MedImmune
10. Pinnacle Biologics Announces Contract With Chiltern
11. Pinnacle Biologics Announces Logistics Services Agreement With the Movianto Group
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/20/2013)... (PRWEB) June 20, 2013 The ... outcomes measurement because of variability in Patient-Reported Outcomes ... sensitivity of such scales to culture, their cross-cultural ... laboratory testing for the successful development of a ... steps for maximizing cross-cultural equivalence of scales assessing ...
(Date:6/20/2013)... 20, 2013 Based on its recent ... Sullivan presents bitop AG with the 2013 European ... The company,s path-breaking extremolyte platform enables a naturally-derived ... dry eye or dry nose syndrome, and respiratory ... to revolutionize how allergies are treated. ...
(Date:6/20/2013)... June 20, 2013 Over the years, ... has received many questions that can be summed up in ... Owner of GLM Displays, Matt Lunser, sat down and ... between his products and offer some useful tips on how ... , “This buyer's guide is meant to help our clients ...
(Date:6/20/2013)... Belatrix Software, the leading global Nearshore Agile ... latest initiative – the Belatrix Software Innovation University (BSIU). ... and business and technology executives to participate in a ... the initiative is to fuel business leaders with what ... innovation efforts. It’s that inspiration that has the ...
Breaking Biology Technology:Cross-Cultural Qualitative Research for Simultaneous Scale Development, New Life Science Webinar Hosted by Xtalks 2Frost & Sullivan Presents bitop AG with the 2013 New Product Innovation Award in the Extremolytes Therapeutics Market 2Frost & Sullivan Presents bitop AG with the 2013 New Product Innovation Award in the Extremolytes Therapeutics Market 3Frost & Sullivan Presents bitop AG with the 2013 New Product Innovation Award in the Extremolytes Therapeutics Market 4Belatrix Software Kicks off Major Innovation Effort and Invites Innovation Expert to Share How Agile + Design Thinking Accelerate Product Innovation 2
... 2011 K-V Pharmaceutical Company (NYSE:  KVa/KVb) announced today ... divest Nesher Pharmaceuticals, Inc., its generics subsidiary, and the ... Inc. for approximately $60 million in cash. The transaction ... KV,s 2012 fiscal year, subject to customary closing conditions. ...
... they left a trail of breadcrumbs to find their ... System (GPS), WiFi, and Bluetooth are the digital signals ... helping us find our location and map our routes. ... few exceptions, today,s firefighters still rely on 20th-century radios, ...
... Background : The U.S. House of Representatives ... appropriations bill, co-sponsored by Rep. Don Young (R-AK) and Rep. ... Drug Administration approval of salmon grown from AquaBounty Technologie,s AquAdvantage ... ten of the total 435 House members. ...
Cached Biology Technology:K-V Pharmaceutical Announces Divestiture of Generics Business to Zydus 2K-V Pharmaceutical Announces Divestiture of Generics Business to Zydus 3K-V Pharmaceutical Announces Divestiture of Generics Business to Zydus 4K-V Pharmaceutical Announces Divestiture of Generics Business to Zydus 5K-V Pharmaceutical Announces Divestiture of Generics Business to Zydus 6K-V Pharmaceutical Announces Divestiture of Generics Business to Zydus 7Wireless 'breadcrumbs' that wont become toast when baked...or soggy when hosed 2Wireless 'breadcrumbs' that wont become toast when baked...or soggy when hosed 3Statement by Ronald L. Stotish, Ph.D., President and CEO of AquaBounty Technologies 2
(Date:6/19/2013)... , June 20, 2013 Based ... market, Frost & Sullivan recognizes geneOnyx Limited with ... New Product Innovation. geneOnyx leverages a DNA testing ... create an on-the-spot genetic test for anti-aging cosmetics. ... DNA collection procedure from saliva to examine single ...
(Date:6/19/2013)... network in Tanzania is playing a vital role in ... west in response to climate and environmental changes, according ... Using data on savannah birds from the Tanzanian Bird ... over recent decades - the researchers found that they ... move to areas further west where dry seasons are ...
(Date:6/19/2013)... 2013   Mercy Medical Center ... for conducting on-demand, Hemoglobin A 1c ... as analysis of important red blood cell, ... new system enables the hospital to provide ... and their patients, which can improve treatment ...
Breaking Biology News(10 mins):Frost & Sullivan Applauds geneOnyx for its DNA Testing Solution for the Personalized Cosmeceuticals Market 2Frost & Sullivan Applauds geneOnyx for its DNA Testing Solution for the Personalized Cosmeceuticals Market 3Frost & Sullivan Applauds geneOnyx for its DNA Testing Solution for the Personalized Cosmeceuticals Market 4Protected areas provide African birds with stepping stones to survival 2Mercy Lab Offers Faster On-demand Diabetes Testing, Cellular Studies 2Mercy Lab Offers Faster On-demand Diabetes Testing, Cellular Studies 3Mercy Lab Offers Faster On-demand Diabetes Testing, Cellular Studies 4
... In much of Africa, a herd of cattle is ... dowry, funeral fund, symbol of wealth, and hedge against drought. ... cow to disease can spell ruin. Yet a grievous ... puts annual losses from disease at $40 billion, some twenty-five ...
... HOUSTON -- (Aug. 17, 2010) -- The most robust statistical ... Eve" -- the maternal ancestor of all living humans -- ... University study was based on a side-by-side comparison of 10 ... lived using a very different set of assumptions about the ...
... could lead to a brand new class of drugs to ... and back pain without numbing the whole body. ... Council (BBSRC) and working at UCL (University College London), have ... pain are regulated by molecules inside cells called small RNAs. ...
Cached Biology News:Cow vaccines go vroom 2Cow vaccines go vroom 3Mother of all humans lived 200,000 years ago 2Mother of all humans lived 200,000 years ago 3Scientists uncover Achilles heel of chronic inflammatory pain 2
... Shimadzus GCMS-QP2010s Gas Chromatograph/Mass Spectrometer, utilizing ... the GCMS-QP2010 Plus, offers high throughput ... an excellent performance-to-cost ratio. Like the ... constant linear velocity for optimum separation, ...
... combines a single-channel sample processing head, an ... reagent dispenser all in one compact, affordable ... pipette tips, the Precision XS autoclavable and ... available for transferring larger volumes. Intuitive Precision ...
... world of discovery races ever faster, you need ... fast track. So our constant focus is on ... research. Thats why our Biomek 3000 Laboratory Automation ... advanced as it is flexible. By integrating all ...
... Zymeds MaxArray Rabbit Tissue Arrays contain 60 ... slides. Each package contains 4 unstained slides and ... your reference. Each slide contains 15 different tissues ... 60 tissue samples per slide. Each tissue sample ...
Biology Products: